Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts

Endocrinology

Volumn 139, Issue 11, 1998, Pages 4672-4678

  Levine, Alice C ^a,b   Liu, Xin Hua ^a   Greenberg, Pietra D ^a   Eliashvili, Mark ^a   Schiff, Jonathan D ^a   Aaronson, Stuart A ^a   Holland, James F ^a   Kirschenbaum, Alexander ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; COMPLEMENTARY DNA; MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL GROWTH; CONTROLLED STUDY; FETUS; FIBROBLAST CULTURE; GENE EXPRESSION REGULATION; GROWTH REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; STROMA CELL;

EID: 0031736024     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.11.6303     Document Type: Article

References (47)

1. Cunha GR, Chung LWK, Shannon JM, Aguchi O, Fuji H 1983 Hormone-induced morphogenesis and growth: role of mesenchymal-epithelial interactions. Recent Prog Horm Res 39:559-598
2. Chung LWK, Cleave ME, Hsieh JT, Hong S-J, Zhau HYE 1991 Reciprocal mesenchymal-epithelial interaction affecting prostate tumor growth and hormonal responsiveness. Cancer Surv 11:91-121
3. Kyprianou N, English HF, Isaacs JT 1990 Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res 50:3748-3753
4. Kirschenbaum A, Ren M, Levine AC 1993 Enhanced androgen sensitivity in serum-free medium of a subline of the LNCaP human prostate cancer cell line. Steroids 58:439-443
5. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Ming Chu T, Mirand EA, Murphy GP 1983 LNCaP model of human prostatic carcinoma. Cancer Res 43:1809-1813
6. Gleave ME, Hsieh JT, Von Eschenbach AC, Chung LWK 1992 Prostate and bone fibroblasts induce human prostate cancer growth in vivo: implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasis. J Urol 147:1151-1159
7. Kirschenbaum A, Wang J-P, Ren M, Schiff JD, Aaronson SA, Droller MJ, Ferrara N, Holland JF, Levine AC 1997 Inhibition of vascular endothelial cell growth factor suppresses the in vivo growth of human prostate tumors. Urol Oncol 3:3-10
8. Folkman J 1990 What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-7
9. Hanahan D, Folkman J 1996 Patterns and emerging mechanisms of angiogenic switch during tumorigenesis. Cell 86:353-364
10. Folkman J 1995 Tumor angiogenesis. In: Mendelssohn J, Howley P, Liotta LA, Israel M (eds) The Molecular Basis of Cancer. WS Saunders, Philadelphia, pp 206-232
11. Klagsbrun M, D'Amore PA 1991 Regulation of angiogenesis. Annu Rev Physiol 53:217-239
12. Ferrara N, Houck K, Jakeman L, Leung DW 1992 Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18-32
13. Kirn KJ, Li B, Winer J, Armamini M, Gillett N, Phillips HS, Ferrara N 1993 Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362:841-84
14. Zhang H-T, Craft P, Scott PAE, Ziche M, Weich HA, Harris AL, Bicknell R 1995 Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst 87:213-219
15. Gridley DA, Andres ML, Slater JM 1997 Enhancement of prostate cancer xenograft growth with whole-body radiation and vascular endothelial growth factor. Anticancer Res 17:923-928
16. Hlatky L, Tsionou C, Hahnfeldt P, Coleman CN 1994 Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. Cancer Res 54:6083-6086
17. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi B-Z 1996 Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271:736-741
18. Warren RS, Yuan H, Matli MR, Ferrara N, Dornner DB 1996 Induction of vascular endothelial growth factor by insulin-like growth factor I in colorectal carcinoma. J Biol Chem 271:29483-29488
19. Hyder SM, Stancel GM, Chiappetta C, Murthy L, Boettger-Tong HL, Makela S 1996 Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen. Cancer Res 56:3954-3960
20. McLaren J, Prentice A, Charnock-Jones DS, Millican SA, Muller KH, Sharkey AM, Smith SK 1996 Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest 98:482-489
21. Nakamura J, Savinov A, Lu Q, Brodie A 1996 Estrogen regulates vascular endothelial growth/permeability factor expression in 7,12 dimethylbenz(a) anthracene-induced rat mammary tumors. Endocrinology 137:5589-5596
22. Heiss JD, Papavassiliou E, Merrill MJ, Nieman L, Knightly JJ, Walbridge S, Edwards NA, Oldfield EH 1996 Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. J Clin Invest 98:1400-1408
23. Joseph IBJK, Isaacs JT 1997 Potentiation of the antiangiogenic ability of Iinomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers. Cancer Res 57:1054-1057
24. Levine AC, Ren M, Huber GK, Kirschenbaum A 1992 The effect of androgen, estrogen, and growth factors on the proliferation of cultured fibroblasts derived from human fetal and adult prostates. Endocrinology 130:2413-2419
25. Liu XH, Wiley HS, Meikle AW 1993 Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-2 and epidermal growth factor receptor. J Clin Endocrinol Metab 77:1472-1478
26. Greenberg ME 1988 Identification of newly transcribed RNA. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Smith JA, Seidman JG, Strahl K (eds) Current Protocols in Molecular Biology. John Wiley and Sons, New York, pp 4.10.1-4.10.8
27. Howard LA, Ortlepp SA 1989 A simplification of the nuclear run-off transcription assay. Biotechniques 7:940-942
28. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
29. Claffey KP, Brown LF, del Aguila LF, Tognazzi K, Yeo K-T, Manseau EF, Dvorak HF 1996 Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res 56:172-181
30. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gersenstein M, Fahrig M, Vandenhhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A 1996 Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439
31. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KD, Powell-Braxton L, Hillan KJ, Moore MW 1996 Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442
32. Shalaby F, Rossant J, Yamaguchi TP, Gersensfein M, Wu XF, Breitman ML, Schuh AC 1995 Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66
33. Fong GH, Rossant J, Gersenstein M, Breitman ML 1995 Role of the Flt-1 tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66-70
34. Asano M, Yukita A, Matsumoto T, Kondo S, Suzuki H 1995 Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor. Cancer Res 55:5296-5301
35. Jackson MW, Bentel JM, Tilley WD 1997 Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia. J Urol 157:2323-2328
36. Ferrer FA, Miller LJ, Andrawis RI, Kurtzman SH, Albertsen PC, Laudone VP, Kreutzer DL 1997 Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells. J Urol 157:2329-2333
37. Brown LF, Yeo K-T, Berse B, Morgentaler A, Dvorak HF, Rosen S 1995 Vascular permeability factor (vascular endothelial growth factor) is strongly expressed in the normal male genital tract and is present in substantial quantities in semen. J Urol 154:576-579
38. Folkman J 1998 Editorial: is tissue mass regulated by vascular endothelial cells: prostate as the first evidence. Endocrinology 139:441-442
39. Cullanin-Bove K, Koos RD 1993 Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology 133:829-837
40. Punglia RS, Lu M, Hsu J, Kuroki M, Tolentino MJ, Keough K, Levy AP, Levy NS, Goldberg MA, D'Amato RJ, Adamis AP 1997 Regulation of vascular endothelial growth factor expression by insulin-like growth factor I. Diabetes 46:1619-1626
41. Levine AC, Wang J-P, Ren M, Eliashvili E, Russell DW, Kirschenbaum A 1996 Immunohistochemical localization of steroid 5α-reductase 2 in the human male fetal reproductive tract and adult prostate. J Clin Endocrinol Metab 81:384-389
42. Alarid ET, Rubin JS, Young P, Chedid M, Ron D, Aaronson SA, Cunha GR 1994 Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proc Natl Acad Sci USA 91:1074-1078
43. Sugimura Y, Foster BW, Horn YK, Lipschutz JH, Rubin JS, Finch PW, Aaronson SA, Hayashi N, Kawamura J, Cunha GR 1996 Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate. Int J Dev Biol 40:941-951
44. Levine AC, Liu X-L, Ren M, Wang J-P, Schiff JD, Diamond EJ, Finch PW, Aaronson SA, Kirschenbaum A 1998 Androgenic effects on prostate specific antigen secretion by human fetal prostate are mediated by keratinocyte growth factor. Mol Urol 2:71-78
45. Franck-Lissbrant I, Haggstrom S, Damber J-E, Bergh A 1998 Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats. Endocrinology 139:451-456
46. Hartley-Asp B, Vukanovic J, Joseph IBJK, Strandgarden K, Polacek J, Isaacs JT 1997 Anti-angiogenic treatment with Linomide as adjuvant to surgical castration in experimental prostate cancer. J Urol 158:902-907
47. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Garvery VS, Dvorak HF 1983 Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985